FORE-SIGHT: Edwards Lifesciences Takes Over CAS Medical Systems for $100M
This CASMED acquisition is expected to strengthen Edwards Lifesciences' (EW) critical care portfolio and expand its footprint in the smart monitoring technology market.
Read full article »
FORE-SIGHT designs and manufactures cerebral oximetry devices for monitoring and measuring tissue oxygenation in the brain.
Read more